Registration and Coffee

High Availability Laboratory Automation
Mike Ouren, Sales Engineer, Precise Automation LLC, United States of America

The ultimate metric of success for a laboratory automation system, is it's popularity with users.

Coffee and Networking

From Clinical Sample to Laboratory Measurement: Automating Epidemiological Research
Matt Sims, Head, University of Cambridge, United Kingdom

The presentation will highlight how different high-throughput laboratory systems are being used to support studies focussed on type 2 diabetes, obesity and other metabolic disorders.

An Automation Platform for the Discovery of Biomolecules
Michael Strerath, Dr, Bayer Healthcare, Germany

The presentation will focus on automated solutions within the discovery platform for novel biomolecules at Bayer Healthcare AG including high throughput screening approaches as well as medium scale laboratory automation.

Lunch and Networking

The Urgent Need for Computation and Automation in the Standardisation of Biobank SOPs in Neurological Disorders
Rivka Ravid, Brain Bank Consultant, Royal Dutch Academy of Sciences, Netherlands

Targeted and personalized therapies for CNS disorders strongly rely upon the availability of large cohorts of samples. Computation and robotics as well as proper specimen management are mandatory for information technology, multi-centre collection and tracking, research queries, joint data formats and internationally accepted software tools.

Large-scale Classification Analysis of Small-volume Samples by Laser-based Mass Spectrometry Profiling
Rainer Cramer, Professor, University of Reading, United Kingdom

In this presentation, general aspects of automation and small sample volume handling will be discussed with respect to their application in high-speed and high-sensitivity/specificity MS analysis of clinical, food and environmental samples.

Perspective for the Next Generation DNA Sequencing Techniques and Applications
Wilhelm Ansorge, Professor, Ecole Polytechnique Federale de Lausanne, Switzerland

Coffee and Networking

Programmable Droplets as Virtual Microwells: A New Paradigm in Automation and Miniaturization
Jean-Louis Viovy, Group Leader, Institut Curie, France

High Throughput Cell Factory Screening by Picoliter Droplet Microfluidics
Hakan Jonsson, Group Leader, Royal Institute of Technology, Sweden

Cell factories are the producer cells critical to biosustainable industry, producing biofuels, chemicals or biopharmaceuticals. Microfludic tools, assays and high throughput screens of picoliter encapsulated single cells and clones of industry cell factories are presented.

Close of Day One

Registration and Coffee

Liquid Handling, Automation and Robotics: Godot vs. Andrew
Piero Zucchelli, Chief Executive Officer, Andrew Alliance, Switzerland

Often, the most important user benefits don't come from new technologies - but from a different use of the available ones.

Coffee and Networking

Multiplexed Microfluidic System for the Automated Analysis of Stem Cell Characteristics
Nicolas Szita, Professor, University College London, United Kingdom

Automated and non-invasive quantification of key characteristics of a stem cell culture: cell numbers, cellular proliferation and morphology, oxygen tensions and uptake rate, including specific oxygen uptake rate. All within a tightly controlled microfluidic cell culture chamber.

New Trends in Intelligent Robotics in the Laboratory: Towards Analytical Laboratory Robotics
Patrick Courtney, Leader, tec-connection, Germany

This presentation will highlight new developments in robotics manipulation and interaction which have the potential to take the laboratory to the next level of functionality, efficiency and safety.

Automated High Throughput Discovery of Bispecific Antibodies via Controlled Fab-arm Exchange
Arnout Gerritsen, Associate Director, Genmab BV, Netherlands

Lunch and Networking

What Do Users Really Expect From an ELN?
Peter Boogaard, Director/Founder, Industrial Lab Automation, Netherlands

This presentation will give an overview of ELN capabilities, share EU survey and explain LIMS vs ELN.

MS Triggered Fraction Collection on Multi Hundred Gramm Scale
Luigi La Vecchia, Director, Novartis Institutes for BioMedical Research, Switzerland

In the presentation an overview will be given on how the GDC Synthesis and Technologies Team of the Novartis Institute for Biomedical Research has dramatically reduced the purification of crude chemical compounds by introducing MS Triggered fraction collection on larger scale.

Coffee & Networking

Eliminating the Dull, Dangerous and Dirty = Why a Global Automation Strategy is Critical for Successful Implementation
Julie Huxley-Jones, Research & Development Head, GlaxoSmithKline Pharmaceuticals, United States of America

Learn about how GSK is making a change in automation, increasing our use of platforms and robotics across the R&D organisation. Understand how cultural and technical change are needed.

Future Challenges for Lab Automation Equipment to Make Data Factories Out of Labs
Andreas Traube, Head of Department, Laboratory Automation and Biomanufacturing Engineering Fraunhofer IPA, Germany

Close of Conference